Stay
up-to-date
about
RECOVER
Our understanding of Long COVID is constantly evolving with new research findings. Stay informed by reading the latest news and participating in upcoming events.
NIH leaders will discuss the current status of RECOVER-TLC, share information about potential Long COVID treatments to be tested in RECOVER-TLC clinical trials, and answer questions from the public.
RECOVER-TLC invites the Long COVID community to submit ideas for potential Long COVID treatments and biomarkers, volunteers for working groups, and provide feedback on the next phase of Long COVID clinical trials.
Researchers across NIH are sharing expertise, data, and innovative research tools to make discoveries that could help improve the lives of people with Long COVID.
A research team at RECOVER’s South Dakota study site prioritizes diversity and accessibility in clinical trial enrollment.
RECOVER researchers at the University of New Mexico study site have built connections between RECOVER studies and the university’s Long COVID clinic to ensure patients have access to resources and care.
Findings from this RECOVER study could inform future efforts to prevent Long COVID using repurposed prescription drugs.
Researchers within and beyond RECOVER can apply to use the initiative’s study data and biosamples for independent research projects.
Researchers studied symptoms in more than 5,300 children and adolescents in RECOVER’s pediatric observational study, 3,860 of whom had a previous COVID infection.
RECOVER study sites and community-based organizations work together to improve understanding of Long COVID and discuss how to better help people and communities impacted by the condition.
Media InquiriesAre you a member of the media or press? Please direct inquiries to the RECOVER@nih.gov inbox. Please place "MEDIA INQUIRY" in your subject line.